REG1VRevenio Group Oyj
14.72EUR+3.23%Mkt Cap: 465.46M $P/E: 24.95

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company of…

Key Statistics

Company
Market Cap465.46M $
Enterprise Value409.67M $
Revenue (TTM)120.70M $
Gross Profit84.57M $
Net Income (TTM)18.93M $
Revenue/Share4.520 USD
Last Price14.72 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees246
CountryFI
SectorHealthcare
IndustryMedical Devices
ISINFI0009010912
Valuation
P/E (Trailing)24.95
P/E (Forward)14.83
PEG6.37
EV/EBITDA15.70
EV/Revenue3.39
P/S3.77
P/B3.34
EPS (TTM)0.59
EPS (Forward)0.97
52W Range
11.8620% of range25.85
52W High25.85 EUR
52W Low11.86 EUR
Profitability
Gross Margin70.94%
Oper. Margin8.43%
EBITDA Margin21.61%
Profit Margin15.88%
ROE15.18%
ROA11.56%
Growth
Revenue Growth4.60%
Earnings Growth-41.40%
Cash Flow & Leverage
Operating CF32.86M $
CapEx (TTM)4.54M $
FCF Margin12.47%
FCF Yield3.23%
Net Debt-11.52M $
Net Debt/EBITDA-0.44
Balance Sheet
Debt/Equity0.10
Current Ratio2.27
Quick Ratio1.76
Book Value/Sh4.317 EUR
Cash/Share0.7880 EUR
Dividends
Fwd Div Rate0.4000 EUR
Trail. Div Rate0.4400 EUR
Div. Yield2.04%
5Y Avg Yield1.21%
Payout Ratio67.85%
Ex-Div DateApr 11, 2025
Pay Date
Splits
Last Split2:1
Split DateMar 20, 2020
Analyst Consensus
Rating
Target (Mean)19.38 EUR
Upside (mean)+31.6%
Target Range15.00 EUR23.50 EUR
15.00+31.6% to mean23.50
# Analysts4
Ownership
Shares Out.29.09M
Float25.16M
Insiders9.65%
Institutions50.98%
Technical
SMA 5012.77 (+15.3%)
SMA 20017.43 (-15.6%)
Beta0.85
S&P 52W Chg18.16%
Avg Vol (30d)49.43K
Avg Vol (10d)72.14K
Technical Indicators
RSI (14)71.4
MACD0.5060
MACD Signal0.3375
MACD Hist.+0.1685
BB Upper15.05 EUR
BB Middle13.29 EUR
BB Lower11.52 EUR
BB Width26.59%
ATR (14)0.4646 EUR
Vol Ratio (20d)0.65x